Document ID: chunk:federal_register_of_legislation:F2019L01095:reg:9:p2
Version: federal_register_of_legislation:F2019L01095
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 6406–9684

Examples of neoplasms or mass lesions involving the middle ear include, but are not limited to:
               (a)                       cholesteatoma;
               (b)       granuloma; and
               (c)         neuroendocrine adenoma.

         (11)      having a disease from the specified list of autoimmune diseases, at the time of the clinical onset of conductive hearing loss;
Note: specified list of autoimmune diseases is defined in the Schedule 1 – Dictionary.

         (12)      undergoing a course of therapeutic radiation for cancer, where the conductive hearing apparatus of the affected side was in the field of radiation, before the clinical onset of conductive hearing loss;
Note: conductive hearing apparatus is defined in the Schedule 1 – Dictionary.

         (13)      having otosclerosis on the affected side at the time of the clinical worsening of conductive hearing loss;

         (14)      having a disease from the specified list of bone diseases, involving the conductive hearing apparatus of the affected side, at the time of the clinical worsening of conductive hearing loss;
            Note:  conductive hearing apparatus and specified list of bone diseases are defined in the Schedule 1 - Dictionary.

         (15)      having an episode of otitic barotrauma involving the affected ear, within the seven days before the clinical worsening of conductive hearing loss;

         (16)      being exposed to a peak sound pressure level at the tympanic membrane of at least 140 dB(C), within the seven days before the clinical worsening of conductive hearing loss;
Note: dB(C) is defined in the Schedule 1 - Dictionary.

         (17)      being exposed to an explosive blast within the seven days before the clinical worsening of conductive hearing loss;

         (18)      being struck by lightning within the seven days before the clinical worsening of conductive hearing loss;

         (19)      having blunt trauma, penetrating trauma or surgery, involving the conductive hearing apparatus of the affected ear, within the seven days before the clinical worsening of conductive hearing loss;
Note: conductive hearing apparatus is defined in the Schedule 1 - Dictionary.

         (20)      having acquired, permanent narrowing or obstruction of the external auditory canal of the affected ear, at the time of the clinical worsening of conductive hearing loss;
            Note 1: Examples of causes of narrowing or obstruction of the external auditory canal include, but are not limited to:
               (a)        benign fibro-osseous lesion;
               (b)       benign or malignant neoplasm;
               (c)        chronic otitis externa;
               (d)       exostosis of the external auditory canal;
               (e)        granuloma; and
               (f)        necrotising otitis externa.
Note 2:  exostosis of the external auditory canal is defined in the Schedule 1 – Dictionary.

         (21)      having chronic otitis media, involving the middle ear of the affected side, at the time of the clinical worsening of conductive hearing loss;
Note: chronic otitis media is defined in the Schedule 1 - Dictionary.
(22)      having:
(a)          a benign or malignant neoplasm; or
(b)          other mass lesion;